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It has been shown in vivo that patients with the
depigmentation disorder vitiligo accumulate hydro-
gen peroxide (H2O2) accompanied by low catalase
levels and high concentrations of 6- and 7-biopterin
in their epidermis. Earlier it was demonstrated that
epidermal 4a-OH-tetrahydrobiopterin dehydratase,
an important enzyme in the recycling process of
6(R)-L-erythro 5,6,7,8 tetrahydrobiopterin (6BH4),
has extremely low activities in these patients conco-
mitant with a build-up of the abiogenic 7-isomer
(7BH4), leading to competitive inhibition of epider-
mal phenylalanine hydroxylase. A topical substitution
for the impaired epidermal catalase with a pseudoca-
talase effectively removes epidermal H2O2, yielding a
recovery of epidermal 4a-OH-tetrahydrobiopterin
dehydratase activities and physiologic 7BH4 levels in
association with successful repigmentation demon-
strating recovery of the 6BH4 recycling process.
Examination of recombinant enzyme activities,
together with 4a-OH-tetrahydrobiopterin dehydra-
tase expression in the epidermis of untreated
patients, identi®es H2O2-induced inactivation of this
enzyme. These results are in agreement with analysis
of genomic DNA from these patients yielding only
wild-type sequences for 4a-OH-tetrahydrobiopterin
dehydratase and therefore ruling out the previously
suspected involvement of this gene. Furthermore,
our data show for the ®rst time direct H2O2 inactiva-
tion of the important 6BH
4
recycling process. Based
on this observation, we suggest that H2O2 derived
from various sources could be a general mechanism
in the regulation of all 6BH4-dependent processes.
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P
atients affected with the depigmentation disorder
vitiligo express a characteristic ¯uorescence in their
white skin patches upon Wood's light (351 nm)
examination (Schallreuter et al, 1994a, b). In this
context, it was demonstrated that this phenomenon
originates from the accumulation of oxidized pterins (Schallreuter
et al, 1994a, b). In the presence of molecular oxygen 6(R)-L-
erythro 5,6,7,8 tetrahydrobiopterin (6BH4) is the immediate
electron donor for the hydroxylation of the aromatic amino acids
L-phenylalanine, L-tyrosine, and L-tryptophan (Kaufman and
Fisher, 1974). Hence, 6BH4 functions as an important regulator
in the synthesis of the neurotransmitters serotonin (Friedman et al,
1972) and catecholamines (Nagatsu et al, 1964). L-tyrosine is the
central substrate for both human epidermal undifferentiated
keratinocytes and melanocytes to initiate catecholamine synthesis
and melanogenesis in these cells. Under normal physiologic
conditions, both cell types hold the full capacity for de novo
synthesis/recycling/regulation of 6BH4 (Schallreuter et al, 1994a,
b). It has also been demonstrated that 6BH4 can regulate tyrosinase
(EC 1.14.18.1) by uncompetitive inhibition (Wood et al, 1995).
Figure 1 presents a scheme for the de novo synthesis/recycling/
regulation of 6BH4 and its link to melanocytes and keratinocytes.
In this context, it was realized that patients with vitiligo show an
increased epidermal de novo synthesis and recycling of this cofactor
in association with barely detectable 4a-OH-tetrahydrobiopterin
dehydratase (DH; EC 4.2.1.96) activities (synonyms: pterin 4 alpha
carbinolamine dehydratase (PCD), dimerization cofactor of
hepatocyte nuclear factor 1 a (DCoH)) (Schallreuter et al, 1994a;
1994b). This enzyme is of major importance in the recycling
process of 6BH4 (Kaufman, 1970; Huang et al, 1973; Ayling et al,
1997) (Fig 1). Low activities of DH can lead to the accumulation of
the abiogenic 7-isomer (7BH4) (Curtius et al, 1990; Davis et al,
1991; Adler et al, 1992), which is a potent competitor of the natural
cofactor 6BH4, hence severely affecting phenylalanine hydroxylase
(PAH; EC 1.14.16.1) activities (Davis et al, 1992). Decreased PAH
activities were indeed demonstrated in the skin of patients with
vitiligo (Schallreuter et al, 1994a, b). One consequence of low
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1In this study we used the pseudocatalase formulation (PC-KUS).
epidermal PAH activities in these patients is an increase in
epidermal L-phenylalanine levels (Schallreuter et al, 1994a, b; ,
1998), which has been con®rmed by in vivo Fourier transform
Raman spectroscopy (FT-Raman spectroscopy). This amino acid
resolves as a well-de®ned peak at 1004 cm±1 (Schallreuter et al,
1998). Both the epidermal L-phenylalanine and 7BH4 build-up,
together with decreased PAH and DH activities, lead to the
generation of hydrogen peroxide (H2O2) in the skin due to an
increased short circuit in the recycling process of 6BH4 (Davis et al,
1992; Schallreuter et al, 1999) (Fig 1). To date several other
impaired metabolic steps have been identi®ed in this disorder
yielding an accumulation of H2O2 in the epidermal compartment
(Schallreuter et al, 1996; 1999; Maresca et al, 1997). On the one
hand, it was only recently that in vivo noninvasive FT-Raman
measurements on the skin of this patient group con®rmed high
concentrations of H2O2 (Schallreuter et al, 1999). On the other
hand, accumulation of H2O2 can deactivate catalase (Aronoff,
1965). In this context, low catalase levels, as well as low glutathione
peroxidase levels, have been identi®ed in patients with vitiligo
(Schallreuter et al, 1991; Maresca et al, 1997; Beazley et al, 1999).
Moreover, these results are in agreement with various degrees of
vacuolation/lipid peroxidation in epidermal cells of vitiligo skin
biopsies described by many groups (Moellmann et al, 1982; Bhawan
and Bhutani, 1983; Gokhale and Mehta, 1983; Tobin et al, 2000).
H2O2 accumulation can oxidize 6BH4 as well as 7BH4 (Armarego
et al, 1983; Armarego, 1984; Schallreuter et al, 1999) and
6-biopterin is cytotoxic to melanocytes (Schallreuter et al, 1994c).
Here, it is noteworthy that both oxidation products can explain the
characteristic ¯uorescence of the depigmented/white skin in these
patients (Schallreuter et al, 1994a, b). This fundamental scienti®c
observation led to the development of a pseudocatalase as a
substitution for the impaired H2O2 degrading systems (Schallreuter
et al, 1995, 1999). The topical application of this narrow band
(311 nm) ultraviolet B (UVB) activated complex yielded four
fundamental clinical results: (i) the arrest of an active depigmenta-
tion process in 95% of the patients (Schallreuter et al, 1995, 1999);
(ii) the recovery of epidermal cells from intracellular vacuolation
(Schallreuter et al, 1999; Tobin et al, 2000); (iii) a successful
repigmentation in 60%±65% of all patients treated so far (n > 700);
and (iv) initiation of repigmentation independent of the duration of
the disease (Schallreuter et al, 1995, 1999). Until now, however, it
remained unknown whether H2O2 accumulation could directly
affect pterin homeostasis in the epidermis. We therefore embarked
on a detailed analysis of the 6BH4 de novo synthesis and recycling
with special emphasis on DH enzyme activity and on DH protein
expression.
Our results identi®ed restored epidermal DH activities in
association with normal 7BH4 levels in patients treated with a
topical pseudocatalase. This observation was accompanied by a
signi®cant decrease/complete loss of epidermal H2O2 con®rmed in
vivo by FT-Raman spectroscopy. The validity of direct H2O2
deactivation of DH has been proven by experiments with pure
recombinant enzyme, as well as with immunohistochemical analysis
of skin sections from treated and untreated patients. Computer
modeling identi®ed a structural change of the enzyme active site of
DH after H2O2 oxidation of the cys81 and trp24 residues. All of the
above observations were supported in patients with vitiligo by an
examination of genomic DH to rule out a suspected point mutation
of this important enzyme. Only wild-type sequences were detected
in the DH coding region in all cases studied. The observations from
this study indicate a general mechanism for H2O2-impaired 6BH4
recycling in this disorder.
Figure 1. De novo synthesis/recycling/regulation of 6BH4 in the production of L-tyrosine by PAH as the substrate for melanogenesis and
catecholamine synthesis. Both epidermal keratinocytes and melanocytes hold the full capacity for an autocrine de novo production/regulation and
recycling of 6BH4 (Schallreuter et al, 1994a, b). Guanosine triphosphate cyclohydrolase I (GTP-CHI) is the rate limiting step in de novo synthesis of 6BH4
using GTP as the starting substrate. 6BH4 serves as the cofactor for the hydroxylation of the essential amino acid L-phenylalanine to L-tyrosine (Kaufman and
Fisher, 1974). L-tyrosine is the substrate for tyrosinase to initiate melanogenesis in melanocytes. It is also the substrate for tyrosine hydroxylase, the rate-
limiting enzyme for catecholamine synthesis in keratinocytes (Schallreuter et al, 1992). Tyrosinase is regulated by 6BH4 through uncompetitive inhibition,
whereas tyrosine hydroxylase requires 6BH4 as a cofactor for the hydroxylation reaction of L-tyrosine to L-DOPA. In addition, PAH produces 4a-OH-BH4
as an intermediate in the recycling process of 6BH4, which is dehydrated by DH to quinonoid dihydropterin (qBH2) followed by the NADPH-dependent
reduction back to 6BH4. During the recycling, the 7-isomer (7BH4), is nonenzymatically produced from 4a-OH-BH4 (Curtius et al, 1990; Davis et al,
1991). 7BH4 can inhibit PAH, as observed in untreated vitiligo (Davis et al, 1992; Schallreuter et al, 1994a). Consequently, the short circuit to qBH2 causes
the formation of H2O2 from O2 and 6BH4 (Kaufman and Fisher, 1974). The de novo synthesis is controlled by the GTP-CHI feedback regulatory protein
(GFRP), where L-phenylalanine upregulates via GFRP the activity of GTP-CHI and 6BH4 exerts the opposite effect (Harada et al, 1993; Milstien et al,
1996).
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MATERIALS AND METHODS
Patients Two independent patient groups and ten healthy age and sex
matched controls served for this investigation. Both studies were approved
by the local Ethics Committee and patient consent forms were obtained
from each patient and control prior to the experiments. All patients and
controls had photo skin type III (Fitzpatrick classi®cation) (Fitzpatrick et al,
1971). The patients expressed the common type vitiligo vulgaris (mean age
50.9 y; range 19±66 y), and the mean duration of the disease at the point of
investigation was 18 y (range 2±44 y). All patients were otherwise healthy
and did not take any additional medication or cosmetics. The ®rst group
included 13 patients for the analysis of pterins and enzyme activities before
and after 6 mo treatment with a UVB-activated pseudocatalase
(Schallreuter, 1999; Schallreuter et al, 1999). The second group included
15 patients for the in vivo FT-Raman measurements of epidermal H2O2
before treatment and 13 d after treatment with a UVB-activated
pseudocatalase.
Cell cultures Human epidermal melanocytes and keratinocytes from
normal healthy probands and patients with vitiligo were established from
suction blister material in MCDB 153 medium using the method of Wille
et al (1984).
Epidermal cell extracts and protein determination Cell extracts
were produced from suction blister roofs using the method of Kiistala
(1968). Protein content of each sample was determined employing the
method of Kalb and Bernlohr (1977).
Analysis of epidermal pterins Total biopterin content was determined
in epidermal cell extracts obtained from suction blister material prior to any
treatment and 6 mo after treatment with pseudocatalase after acidic iodine
oxidation using reverse phase high performance liquid chromatography
(HPLC) following the method from Ziegler and HuÈltner (1992). The
concentration of pterin was calculated on the basis of protein content (Kalb
and Bernlohr, 1977).
PAH activities in epidermal cell extracts PAH activities were
measured in the same epidermal cell extracts as were used for analysis of
pterins using the method of Abita et al (1987; Schallreuter et al, 1994a).
Enzyme activities were determined per mg protein per min.
DH activities in epidermal cell extracts Enzyme activities were
determined in the same epidermal cell extracts as above in a coupled assay
according to Schallreuter et al (1994a).
DH mRNA expression in normal and vitiliginous melanocytes and
keratinocytes Total mRNA was extracted from cells prior to the fourth
passage using Ambions Totally RNA isolation kit (AMS Biotechnology,
Oxfordshire, U.K.) based on the guanidium isothiocyanate method. cDNA
was synthesized using the reverse transcription system (Promega,
Southampton, U.K.) and oligo DT primers, incubated at 42°C for 1 h,
followed by a 5 min denaturation step at 95°C. Polymerase chain reaction
(PCR) assays were conducted as described previously (Schallreuter et al,
1998).
All primers were obtained from Genoysis Biotechnologies, Europe Ltd,
Pampisford, U.K., and were designed based upon the mRNA sequences of
Genbank accession numbers: DH (L41559), 5¢-GCCATCTTCAAG-
CAGTTTC-3¢ and 5¢-AGTTCAGTCACCCTTTCCC-3¢; b-actin
(M10277); 5¢-ATCTGGCACCACACCTTCTACAATGAGCTGCG-3¢
and 5¢-CGTCATACTCCTGCTTGCTGATCCACATCTGC-3¢.
Primers were added to ®nal concentrations of 1.0 mm and 0.4 mm for
DH and b-actin, respectively. DH reactions contained 10% dimethyl
sulfoxide and all assays were subjected to incubations of 95°C for 5 min
followed by 35 cycles of 95°C 1 min, 55°C 1 min, 72°C 1 min, and a ®nal
extension period of 72°C 11 min. PCR products were analyzed by 1.5%
agarose gel electrophoresis with ethidium bromide staining.
Immunohistochemistry Full-skin biopsies were obtained under local
anesthesia from healthy controls of photo skin type III (n = 8) and from
lesional white and uninvolved skin of patients with vitiligo (n = 10) with
the same photo skin type. Samples were frozen in liquid nitrogen after
cryoprotection. Seven-micron cryosections were allowed to air dry and
were ®xed in acetone for 10 min. Brie¯y, sections were incubated for
90 min at room temperature with the primary polyclonal DH antibody F
3862 (Resibois et al, 1999). Subsequently the sections were incubated for
20 min with a biotinylated secondary antibody followed by peroxidase
labeled acridine (Dako, Carpinteria, CA). AEC was applied as chromogen
(large volume Dako AEC substrate system) under microscopic control with
a Leica DM IRB inverted microscope (Wetzlar, Germany) until the
speci®c staining was visible. For embedding, glycergel mounting medium
(Sigma-Aldrich, Dorset, U.K.) was used. For negative controls the primary
antibody was omitted.
Transformation and puri®cation of rat recombinant DH His-
tagged rat recombinant DH was transformed into Epicurian coli BL21 (DE3)
cells by using a PACYC 9d kanamycin-resistant vector according to the
method of Ficner et al (1995). DH was overexpressed with 2 3 10±3 M
isopropyl-b-D-thiogalactopyranoside. Cells were harvested after 4 h and
DH was partially puri®ed by elution from DEAE-sepharose (1.5 3 10 cm)
using a 100 ml gradient of 0.05±0.5 M NaCl in Tris buffer 0.05 M pH 8.0.
DH fractions were then added to a Hi-Trap His-tagged af®nity column
(5.0 ml) loaded with Ni2+ and eluted by using a 100 ml gradient of 0.005±
1 M imidazole buffer pH 8.0. DH purity was con®rmed by sodium dodecyl
sulfate 12% polyacrylamide gel electrophoresis. DH migrates as a single
band at 14 kDa (data not shown). Note that the sequences of rat and human
DH are identical (Ficner et al, 1995).
DH mutation analysis in nine patients with vitiligo Genomic DNA
was isolated from epidermal sheets of full-skin biopsies and from blood
leukocytes following standard procedures (Sambrook et al, 1989). Mutation
analysis was performed by exon-speci®c ampli®cation and direct DNA
sequencing of the PCR products. The corresponding primer sequences for
PCR and DNA sequencing have been published elsewhere (ThoÈny et al,
1998).
In vivo detection of H2O2 in the epidermis using FT-Raman
spectroscopy FT-Raman spectra were produced with a Bruker RFS
100/S spectrometer equipped with a liquid nitrogen cooled germanium
detector. Sample excitation was accomplished using an Nd3+:YAG laser
operating at 1064 nm. The laser power was 400 mW. Each spectrum was
accumulated from the wrist area over 5 min with 300 scans and a resolution
of 4 cm±1. Total H2O2 was assigned as a well-de®ned peak at 875 cm±1
based on the O±O stretch (Schallreuter et al, 1999a). Levels are expressed in
arbitary units. In vitro experiments show that millimolar concentrations are
required to follow a well-resolved peak at 875 cm±1 (Schallreuter et al,
1999a).
Molecular modeling based on the crystal structure of DH All
molecular models were based on the crystal structure of PCD/DCoH
(Protein Databank accession number 1DCP) (Cronk et al, 1996). For
studies of the active site, a molecular model of the natural substrate 4a-OH-
BH4 was produced with the HyperchemTM suite of programs (Hypercube,
Canada). Geometry optimization was obtained using the MM+ force®eld
(Allinger, 1977). Both stereo isomers of 4a-OH-BH4 were modeled and
substituted in the same location as the product analog. In addition, selected
residues were oxidized to mimic the effects of exposure to H2O2. All
protein structures were optimized with the AMBER force®eld using a
Polak-Ribiere conjugate gradient on a Pentium II personal computer
running at 300 MHz with 64 Mb of memory (Weiner et al, 1986).
Structures were visualized employing Chemscape Chime version 2.03
(MDL Information Systems, San Leandro, CA).
Statistical analysis Statistical analysis was based on the Student's paired t
test on SPSS for Windows.
RESULTS
Presence of millimolar H2O2 concentrations in the
epidermis of patients with vitiligo and its removal by a
pseudocatalase The results of in vivo FT-Raman spectroscopy
con®rmed millimolar H2O2 accumulation in 15 untreated patients
with active, progressive vitiligo. H2O2 was successfully removed
after 13 d treatment with a topical application of a pseudocatalase
(Fig 2).
Recovery of epidermal DH activities and 7BH4 levels We
therefore determined both DH activities as well as 7BH4 levels in
epidermal suction blister material obtained from patients before and
6 mo after initiation of the treatment. The results of all treated
patients showed a restoration of DH activities concomitant with
normal levels of 7BH4 (Figs 3, 4). This observation clearly
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indicates the recovery of the recycling process for 6BH4 after
removal of excessive H2O2 in the epidermis of these patients.
Enzyme activities and pterin levels, however, are determined on
the basis of protein content. Therefore, this value is in¯uenced by
the thickness of the stratum corneum, which does not express any
enzyme activities. Highest activities are always found in
proliferating cells (i.e., the basal layer) with a signi®cant
reduction after differentiation (Schallreuter et al, 1994a; 1994b).
Note that after 6 mo treatment the stratum corneum is always
thicker and therefore total DH activities probably fully recover.
This assumption is supported by the full recovery of 7BH4
production in these patients. Here it should be noted that
signi®cant 7BH4 levels are only produced when DH is absent or
inhibited (Curtius et al, 1988; Davis et al, 1991).
Recovery of DH protein in the epidermis after H2O2
removal In addition to the recovery of DH enzyme activities,
we documented normal expression of DH immunoreactivity using
a polyclonal antibody F 3862 against DH. Figure 5 demonstrates a
signi®cantly higher expression of DH in the basal layer of the
epidermis in both patients and controls. This observation is in
agreement with upregulated proliferation in these cells concomitant
with autocrine 6BH4 production/recycling/regulation and
catecholamine biosynthesis (Schallreuter et al, 1992; Schallreuter,
1997). Untreated patients show a much lower expression of DH
protein compared with treated patients and healthy controls of the
same photo skin type (Fitzpatrick classi®cation) (Fig 5a±c). These
results demonstrate a decrease in protein levels of the enzyme in the
untreated patients in association with epidermal accumulation of
H2O2 (Fig 2). As the expression of DH mRNA from epidermal
melanocytes and keratinocytes (Fig 6) appeared to be unaffected
compared with control cells, it can be suggested that the decrease in
the DH protein as shown in Fig 5(b) could be directly initiated by
H2O2 due to protein instability.
Figure 2. In vivo FT-Raman analysis of epidermal H2O2. In vivo
H2O2 levels in white skin of patients with vitiligo (n = 15) compared with
healthy controls (n = 15) were obtained before and after 13 d of treatment
with pseudocatalase. These data prove the complete reduction of epidermal
H2O2 after treatment with pseudocatalase (p < 0.0001 6 SEM).
Figure 3. Epidermal 7BH4 levels before and after 6 mo treatment
with pseudocatalase compared with healthy controls. The results
demonstrate the recovery of pathologic to normal/physiologic levels of
7BH4 in patients after removal of H2O2 with pseudocatalase (n = 10) (error
bars show standard error of the mean) (p < 0.0001 6 SEM) (normal =
nonlesional, vitiligo = lesional).
Figure 4. DH enzyme activities in epidermal cell extracts before
and after treatment with pseudocatalase. Recovery of DH activities
after 6 mo treatment with pseudocatalase (n = 6) compared with untreated
patients (n = 7) and healthy controls (n = 6) (error bars show standard
deviations). These data con®rm the restoration of enzyme activities in the
6BH4 recycling process in vitiligo after successful removal of H2O2 (r,
nonlesional skin; , lesional skin) (p < 0.001 6 SEM).
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Inactivation of recombinant DH enzyme by H2O2 To
further substantiate this ®nding, we incubated puri®ed
recombinant DH with H2O2 to follow its direct effect on the
enzyme activity. We utilized a coupled assay for this purpose as
DH can stimulate PAH activity (Kaufman, 1970; Huang et al,
1973; Ayling et al, 1997). Figure 7 demonstrates DH-stimulated
PAH activity with a 7-fold increase in the initial rate (V0). This
result is in agreement with Kaufman's earlier report (Kaufman,
1970). After preincubation of DH with H2O2 for 10 min prior
to the PAH assay, however, there was a time-dependent
signi®cant decrease of enzyme activity, con®rming a H2O2-
induced deactivation (Fig 7).
DH active site alteration by H2O2 Molecular modeling of the
natural substrate 4a-OH-BH4 in the active site of DH supports
previous observations that His79 and His61 are responsible for the
catalytic activity of the S- and R-isomers of the substrate (Ayling
et al, 1997). Oxidation of the Cys81 by H2O2, however, affects the
orientation of both of these histidine residues, implicating the loss
of the hydrogen bond from the imidazole ring of His79 to the
hydroxyl group of the S-isomer in position 4a on the pterin
molecule. By contrast, the hydrogen bond from His61 to the
hydroxyl group of the R-isomer remains unaffected. Oxidation of
Trp24 substantially moves both histidine residues and breaks all
possible hydrogen bonds with the pterin, resulting in an inactive
binding site for the substrate (Fig 8a, b). To our knowledge, this
observation identi®es for the ®rst time the direct deactivation of
DH by H2O2. Our results exclude the earlier proposed
involvement of Trp65 (Ficner et al, 1995).
DH is not mutated in vitiligo Originally low epidermal DH
activities implicated the possibility of a leaky mutation in the DH
gene (Schallreuter et al, 1994a). Therefore, the direct effect of
H2O2 on the enzyme described above was further supported by an
investigation of the DH gene to rule out possible point mutations
or mosaics. In all cases studied, we found only wild-type sequences
for the DH coding region (data not shown). Based on these results
we conclude that low DH activities in vitiligo are not caused by a
mutant DH.
DISCUSSION
Over the past the importance of 6BH4 homeostasis in health
and disease has been the subject of numerous reports (Smith,
1974; Blau et al, 1996; Kaufman, 1997). Previous studies
established the presence of a full autocrine 6BH4 synthesis/
recycling/regulation in keratinocytes and melanocytes of the
human epidermis (Schallreuter et al, 1994a; 1994b). Patients
with the depigmentation disorder vitiligo exhibit a severely
impaired epidermal 6BH4 homeostasis together with an
accumulation of H2O2 in this compartment (Schallreuter et al,
1994a, b, 1999). So far it has remained elusive whether the
recycling of 6BH4 (Fig 1) with low DH activities in association
with high levels of the abiogenic 7BH4 could be caused by a
possible mutation of the DH gene or by deactivation of the
enzyme itself in these patients (Schallreuter et al, 1994a, b). The
identi®cation of accumulated 7BH4 is a rather rare event in
pterin metabolism (Curtius et al, 1988, 1990; Davis et al, 1991;
Adler et al, 1992). To date, it still remains obscure whether this
7-isomer has any physiologic function. 7BH4 accumulation has
only been described so far in two disorders, in mild variants of
phenylketonuria (PKU) (Curtius et al, 1988; Dhondt et al, 1988;
Citron et al, 1993; Ayling et al, 2000) and in vitiligo
(Schallreuter et al, 1994a, b). There is one fundamental
difference. Patients affected by the former PKU variants express
a transient mild hyperphenylalanaemia and mutations in the DH
gene (e.g., from T ® C causing a substitution of Cys81 by
Arg81). Patients with vitiligo show no hyperphenylalanaemia
(n = 321) (Schallreuter et al, 1998; Schallreuter, unpublished
results). The results of this study clearly rule out a mutant DH
in vitiligo. The removal of epidermal H2O2 in patients with
vitiligo yields a recovery of DH activities and normal levels of
7BH4 (Figs 3, 4). This observation strongly suggests direct
involvement of H2O2 on this enzyme activity. The immuno-
histochemical approach in this investigation con®rmed the
presence of DH in the epidermis of healthy controls and
untreated/treated patients, predominantly in the basal layer. Our
data support restoration of the protein after removal of H2O2
by pseudocatalase (Fig 5). In addition, we were able to prove
direct deactivation of the enzyme by H2O2 with recombinant
DH and PAH (Fig 7). In this context, it is noteworthy that the
enzyme DH functions as a tetramer of identical subunits,
whereas its dimers serve for the dimerization of the transcription
factor hepatocyte nuclear factor 1 (Ficner et al, 1995; Kim and
Burley, 1995). Studies employing X-ray crystallography eluci-
dated a binding site for the substrate analog 7,8 dihydrobiopter-
in on the enzyme (Ficner et al, 1995). From these studies, it
was proposed that the analog/substrate would bind between the
Figure 5. Epidermal DH expression before and after treatment with
pseudocatalase. Immunohistochemical detection of DH with the primary
monoclonal antibody F 3862 in human skin of (a) a healthy control (photo
skin type III) and a patient with vitiligo (b) before and (c) after 6 mo
treatment with a UVB-activated pseudocatalase. Note the thickening of the
stratum corneum in (c) after treatment. DH is predominantly localized in
the basal layer, whereas upon differentiation of keratinocytes there is a
signi®cantly lower expression of the protein. The section of untreated
vitiligo skin shows signi®cantly lower expression in the basal layer, whereas
after treatment with a pseudocatalase the expression returns back to normal.
As the protein expression recovers after removal of H2O2, this result
suggested that H2O2 affected protein degradation of DH.b
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subunits of the tetramer. Accordingly, Cys81 and Trp65 were
implicated in the vicinity of the catalytic histidine residues in
the binding site (Ficner et al, 1995). As both amino acids would
be susceptible to oxidation via H2O2, we suspected that this
mechanism could account for low DH activities as observed in
vitiligo. Therefore, we examined the entire amino acid
sequence of DH, which offers only four possibilities for
H2O2 oxidation, i.e., Trp
24, Trp65, Cys81, Met102. Computer
modeling using the natural substrate 4a-OH-BH4 clearly
identi®es the oxidation of Cys81, which severely affects the
structure of the active site for the binding of the S-isomer,
whereas the oxidation of Cys81 in the binding of the R-isomer
does not alter the enzyme. However, the oxidation of Trp24
changes the binding site for both isomers (Fig 8a, b). By
contrast, Trp65 and the methionine residue are located in
hydrophobic areas of the protein and therefore do not affect the
overall structure of the enzyme.
Figure 6. DH in vitro mRNA expression in human epidermal
melanocytes and keratinocytes from normal healthy and vitiligi-
nous probands. Qualitative agarose gel electrophoretic analysis of PCR
assays for DH mRNA expression, standardized to b-actin. The order of the
samples on the gel is, from left to right, 100 bp ladder, normal healthy
keratinocyte, normal healthy melanocyte, lesional vitiliginous melanocyte,
lesional vitiliginous keratinocyte, negative control (omission of template
cDNA). This lower expression of melanocyte mRNA can be explained by
the observation that melanins can inhibit the PCR (Eckhart et al, 2000).
Figure 7. The effect of H2O2 on the activation of PAH by DH. The
production of 14C L-tyrosine from 14C L-phenylalanine was followed after
35 min by PAH activity alone (d). The initial rate (V0) of PAH activity was
stimulated 7-fold by the addition of recombinant DH (1:1) (j). In order to
examine the direct in¯uences of H2O2 on DH coupling to PAH, rDH was
preincubated with 10 mM of H2O2 and the activation assay was repeated
showing a time-dependent deactivation of this coupled system (h). Note
that, at the incubation time of 10 min, the initial rate of DH activity (V0) is
only reduced by 40%. After 10 min, however, the active coupling is
terminated, proving the total loss of DH activity by H2O2.
Figure 8. Molecular modeling of the DH ac-
tive site before and after oxidation with
H2O2. (a) Binding of the pterin S-isomer. (b)
Binding of the pterin R-isomer. The substrate 4a-
OH-BH4 is shown in yellow. The backbone of
the active site of the enzyme is demonstrated in
green. The effect of the oxidation of the Cys81 re-
sidue in the enzyme is presented in red and shows
a conformational change only for the S-isomer (a)
whereas the R-isomer does not affect the enzyme
structure (b). The reaction of H2O2 with Trp24
changes the binding of both isomers (white back-
bones). Oxidation of this residue by H2O2 results
in the movement of the active site imidazole rings
of His61 and His79.
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To our knowledge, this paper identi®es for the ®rst time
direct deactivation of the major 6BH4 recycling enzyme, DH,
by H2O2, both in vivo by utilizing the biologic model of the
depigmentation disorder vitiligo and in vitro by employing
recombinant enzymes. In addition, as 6BH4 is an extremely
ubiquitous cofactor involved in several important metabolic
pathways, our observation could indicate a general mechanism
for regulation of the 6BH4 recycling process via H2O2. In this
context, it has recently been shown that H2O2 induces
activation of dendritic cells followed by selective T cell
proliferation (Rutault et al, 1999). As both cell types hold the
capacity for 6BH4 synthesis and recycling, our results presented
in this study could suggest an H2O2/6BH4-mediated control of
the immune response. Current studies in our laboratory are
under way to further elucidate this interesting hypothesis.
Furthermore, it would be of great interest to follow the
in¯uence of H2O2 on the de novo synthesis of 6BH4 in vitiligo.
We wish to acknowledge the constant enthusiasm and donation of skin and blood
samples by the patients. This research has been kindly supported by grants to KUS
from Stiefel Laboratories and the Deutsche Vitiligo Verein e.V., Hamburg,
Germany. We are very grateful to Angela Panske and Magdy Youssef for their
excellent technical assistance. Helen Bartle typed the manuscript.
REFERENCES
Abita JP, Blandin Savoja F, Rey F: Phenylalanine 4-monooxygenase from human
liver. Meth Enzymol 142:27±35, 1987
Adler C, Ghisla S, Rebrin I, et al: 7-Substituted pterins in humans with suspected
pterin-4a-carbinolamine dehydratase de®ciency ± mechanism of formation via
nonenzymatic transformation from 6-substituted pterins. Eur J Biochem
208:139±144, 1992
Allinger NL: Conformational analysis. 130. MM2. A hydrocarbon force ®eld
utilizing V1 and V2 torsional terms. J Am Chem Soc 99:8127±8134, 1977
Armarego WLF: Chemical and biological reactions and reduced pterins. Lect
Heterocycl Chem 7:21±130, 1984
Armarego WLF, Randles D, Taguchi H: Peroxidase catalysed aerobic degradation of
5,6,7,8 tetrahydrobiopterin at physiological pH. Eur J Biochem 135:393±403,
1983
Aronoff S: Catalase: kinetics of photo-oxidation. Science 150:72±73, 1965
Ayling JE, Rebrin I, Bailey SW, ThoÈny B: Mechanisms of dehydration by the
bifunctional protein, 4a-hydroxy-tetrahydropterin dehydratase/DCoH. In:
P¯eiderer W, Rokos H, eds. Chemistry and Biology of Pteridones and Folates,
Berlin: Blackwell Science, 1997: pp 565±570
Ayling JE, Bailey SW, Boerth SR, Giugliani Braegger CP, Thony B, Blau N:
Hyperphenylalanaemia and 7-pterin excretion associated with mutations in 4a-
hydroxy-tetrahydrobiopterin dehydratase/DCoH: analysis of enzyme activity
in intestinal biopsies. Mol Genet Metab 70:179±188, 2000
Beazley WD, Gaze DC, Panske A, Panzig E, Schallreuter KU: Serum selenium
levels and glutathione peroxidase activities in vitiligo. Br J Dermatol 41:301±
303, 1999
Bhawan J, Bhutani LK: Keratinocyte damage in vitiligo. J Cutaneous Path 10:207±
212, 1983
Blau N, ThoÈny B, Spada M, Ponzone A: Tetrahydrobiopterin and inherited
hyperphenylalaninemias. Turk J Pediatr 38:19±35, 1996
Citron BA, Kaufman S, Milstien S, Naylor EW, Greene CL, Davis MD: Mutation in
the 4a-carbinolamine dehydratase gene leads to mild hyperphenylalanaemia
with defective cofactor metabolism. Am J Hum Genet 53:768±774, 1993
Cronk JD, Endrizzi JA, Alber T: High resolution structures of the bifunctional
enzyme and transcriptional coactivator DCoH and its complex with a product
analogue. Protein Sci 5:1963±1972, 1996
Curtius HC, Kuster T, Matasovic A, Blau N, Dhondt JL: Primapterin, anapterin
and 6-oxo-primapterin, three new 7-substituted pterins identi®ed in a
patient with hyperphenylalaninemia. Biochem Biophys Res Commun 153:715±
721, 1988
Curtius HC, Adler C, Rebrin I, Heizmann C, Ghisla S: 7-substituted pterins:
formation during phenylalanine hydroxylation in the absence of dehydratase.
Biochem Biophys Res Commun 172:1060±1066, 1990
Davis MD, Kaufman S, Milstien S: Conversion of 6-substituted tetrahydrobiopterin
to 7-isomers via phenylalanine hydroxylase-generated intermediates. Proc Natl
Acad Sci USA 88:385±389, 1991
Davis MD, Ribeiro P, Tipper J, Kaufman S: ¢7-Tetrahydrobiopterin', a naturally
occurring analogue of tetrahydrobiopterin, is a cofactor for and a potential
inhibitor of the aromatic amino acid hydrolases. Proc Natl Acad Sci USA
89:10108±10113, 1992
Dhondt J, Guibaud P, Rolland M, Dorche C, Andre SK, Forzy G, Hayte J: Neonatal
hyperphenylalaninemia presumably caused by a new variant of biopterin
synthetase de®ciency. Eur J Pediatr 147:153±157, 1988
Eckhart L, Bach J, Ban J, Tschachler E: Melanin binds reversibly to thermostable
DNA polymerase and inhibits its activity. Biochem Biophys Res Commun 3:726±
730, 2000
Ficner R, Sauer UH, Stier G, Suck D: Three-dimensional structure of the
bifunctional protein PCD/DCoH, a cytoplasmic enzyme interacting with
transcription factor HNF1. EMBO J 14:2034±2042, 1995
Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF: Photomedicine. In:
Dermatology in General Medicine, New York: McGraw-Hill, 1971: pp 1692±
1695
Friedman PA, Kappelman AH, Kaufman S: Partial puri®cation and characterization
of tryptophan hydroxylase from rabbit hindbrain. J Biol Chem 247:4165±4173,
1972
Gokhale BB, Mehta LN: Histopathology of vitiliginous skin. Int J Dermatol 22:447±
480, 1983
Harada T, Kagamiyama H, Hatakeyama K: Feedback regulation mechanisms for the
control of GTP cyclohydrolase I activity. Science 260:1507±1510, 1993
Huang CY, Max EE, Kaufman S: Puri®cation and characterisation of phenylalanine
hydroxylase stimulating protein from rat liver. J Biol Chem 248:4235±4241,
1973
Kalb VF Jr, Bernlohr RW: A rapid method for protein determination. Anal Biochem
82:362±371, 1977
Kaufman S: A protein that stimulates rat liver phenylalanine hydroxylase. J Biol Chem
245:4751±4759, 1970
Kaufman S: Tetrahydrobiopterin: Basic Biochemistry and Role in Human Disease,
Baltimore: Johns Hopkins University Press, 1997: p 448
Kaufman S, Fisher DB: Pterin-requiring aromatic amino acid hydroxylases. In:
Hayaishi O, ed. Molecular Mechanisms of Oxygen Activation, New York:
Academic Press, 1974: pp 285±369
Kiistala U: A suction blister device for the separation of epidermis from dermis. J
Invest Dermatol 50:129±137, 1968
Kim JL, Burley SK: PCD/DCoH: more than a second molecular saddle. Structure
3:531±534, 1995
Maresca V, Roccella M, Roccella F, et al: Increased sensitivity to peroxidative agents
as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest
Dermatol 109:310±313, 1997
Milstien S, Jaffe H, Kowlessur D, Bonner TI: Puri®cation and cloning of the GTP
cyclohydrolase I feedback regulatory protein, GFRP. J Biol Chem 271:19743±
19751, 1996
Moellmann G, Klein-Angerer S, Scollay DA, Nordlund JJ, Lerner AB: Extracellular
granular material and degeneration of keratinocytes in the normally pigmented
epidermis of patients with vitiligo. J Invest Dermatol 79:321±330, 1982
Nagatsu T, Levitt M, Udenfriend S: Tyrosine hydroxylase: the initial step in
norepinephrine biosynthesis. J Biol Chem 239:2910±2917, 1964
Resibois A, Cuvelier L, Svoboda M, Heizmann CW, ThoÈny B:
Immunohistochemical localisation of pterin 4a-carbinolamine dehydratase in
rat peripheral organs. Histochem Cell Biol 111:381±390, 1999
Rutault K, Alderman C, Chain BM, Katz DR: Reactive oxygen species activate
human peripheral blood dendritic cells. Free Radic Biol Med 26:232±238,
1999
Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: a Laboratory Manual, Cold
Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989
Schallreuter KU: Epidermal adrenergic signal transduction as part of the neuronal
network in the human epidermis. J Invest Dermatol Symp Proc 2:37±40,
1997
Schallreuter KU: Successful treatment of oxidative stress in vitiligo. Skin Pharmacol
Appl Skin Physiol 12:132±138, 1999
Schallreuter KU, Wood JM, Berger J: Low catalase levels in the epidermis of patients
with vitiligo. J Invest Dermatol 97:1081±1085, 1991
Schallreuter KU, Wood JM, Lemke R, et al: Production of catecholamines in the
human epidermis. Biochem Biophys Res Commun 189:72±78, 1992
Schallreuter KU, Wood JM, Pittelkow MR, et al: Regulation of melanin
biosynthesis in the human epidermis by tetrahydrobiopterin. Science
263:1444±1446, 1994a
Schallreuter KU, Wood JM, Lemke KR, Pittelkow MR, Lindsey NJ, GuÈtlich
M, Ziegler I: Defective tetrahydrobiopterin and catecholamine biosynthesis
in the depigmentation disorder vitiligo. Biochim Biophys Acta 1226:181±192,
1994b
Schallreuter KU, BuÈttner G, Pittelkow MR, Wood JM, Swanson NN, KoÈrner C:
The cytotoxicity of 6-biopterin to human melanocytes. Biochem Biophys Res
Commun 204:43±48, 1994c
Schallreuter KU, Wood JM, Lemke KR, Levenig C: Treatment of vitiligo with
a topical application of pseudocatalase and calcium in combination with
short term UVB exposure: a case study on 33 patients. Dermatol 190:223±
229, 1995
Schallreuter KU, Wood JM, Pittelkow MR, BuÈttner G, Swanson NN, KoÈrner C,
Ehrke C: Increased monoamine oxidase A activity in the epidermis of patients
with vitiligo. Arch Dermatol Res 288:14±18, 1996
Schallreuter KU, Zschiesche M, Moore J, et al: In vivo evidence for compromised
phenylalanine metabolism in vitiligo. Biochem Biophys Res Commun 243:395±
399, 1998
Schallreuter KU, Moore J, Wood JM, et al: In vivo and in vitro evidence for hydrogen
peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its
successful removal by a UVB-activated pseudocatalase. J Invest Dermatol Symp
Proc 4:91±96, 1999
Smith I: A typical phenylketonuria accompanied by a severe progressive neurological
illness unresponsive to dietary treatment. Arch Dis Child 49:245, 1974
ThoÈny B, Neuheiser F, Kierat L, et al: Hyperphenylalaninaemia with high levels of 7-
biopterin is associated with mutations in the PCBD gene encoding the
VOL. 116, NO. 1 JANUARY 2001 ALTERED 6BH4 RECYCLING BY H2O2 ACCUMULATION 173
bifunctional protein pterin 4a-carbinolamine dehydratase and transcriptional
coactivator (DCoH). Am J Hum Genet 62:1302±1311, 1998
Tobin DJ, Swanson NN, Pittelkow MR, Peters EMJ, Schallreuter KU: Melanocytes
are not absent in lesional skin of long duration vitiligo. J Pathol 191:407±416,
2000
Weiner SJ, Kollman PA, Nguyen DT, Case DA: An all atom force ®eld for
simulations of proteins and nucleic acids. J Comput Chem 7:230±252, 1986
Wille JJ, Pittelkow MR, Shipley GD, Scott RE: Integrated control of growth and
differentiation of normal human prokeratinocytes cultured in serum-free
medium: clonal analyses, growth kinetics and cell cycle studies. J Cell Physiol
121:31±44, 1984
Wood JM, Schallreuter-Wood KU, Lindsey NJ, Callaghan S, Gardner MLG: A
speci®c tetrahydrobiopterin binding domain on tyrosinase controls
melanogenesis. Biochem Biophys Res Commun 206:480±485, 1995
Ziegler I, HuÈltner L: Tetrahydro-6-biopterin is associated with tetrahydro-7-
biopterin in primary murine mast cells. FEBS Lett 307:147±150, 1992
174 SCHALLREUTER ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
